Key facts
- This page summarizes Todd E. Simpson's Form 4 filing for Seagen Inc..
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 30 Aug 2023, 19:06.
Todd E. Simpson - 28 Aug 2023 Form 4 Insider Report for Seagen Inc.
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- N/A
- Reported as of
- 28 Aug 2023
- Net transaction value
- -$99,910
- SEC form
- 4
- Accepted by SEC
- 30 Aug 2023, 19:06:13 UTC
- Prior SEC filing
- 17 Aug 2023
- Next SEC filing
- 01 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Jennifer Prosba For: Todd E Simpson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Todd E. Simpson filed Form 4 for Seagen Inc. on 30 Aug 2023.
Change
- Previous filing in this sequence was filed on 17 Aug 2023.
- Current net transaction value: -$99,910.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SGEN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,225
- Change %
- +0.94%
- Price
- $0.000000
- Shares after
- 131,410
- Date
- 28 Aug 2023
- Ownership
- Direct
- Footnotes
- F1, F2
SGEN
transaction
Common Stock
Sale
- Transaction value
- $99,910
- Shares
- -485
- Change %
- -0.37%
- Price
- $206.00
- Shares after
- 130,925
- Date
- 29 Aug 2023
- Ownership
- Direct
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The performance criteria for these restricted stock units were met. These restricted stock units became fully vested on 8/28/2023.
Footnote F2
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
Footnote F3
The sales reported in this Form 4 were effected pursuant to a written plan adopted on 11/5/2020 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).